Vitruvian Partners raises Â£4.71 billionwritten by Bella Palmer
Primarily focussed on Europe, the Fund provides support to businesses seeking international expansion
VIP IV is one of the largest funds focused on supporting high growth companies in the middle market. With a primary focus in Europe, the Fund has global reach with the ability to support businesses seeking assistance with international expansion. Vitruvian is able to provide this global reach through its network of offices across Europe and satellite offices in the US and China.
The fund reached the hard cap quickly, and was over-subscribed, in part due to Vitruvian’s longstanding track record and strong alignment with investors. Vitruvian has generated top-docile performance in each of its three predecessor funds through long-term partnerships with outstanding entrepreneurs and management teams.
It received strong support from both long-term supporters of Vitruvian and new investors, and accepted commitments from over 120 institutions, with over 50 per cent of the Fund raised from North America, c30 per cent from Europe and the balance from Asia and the Middle East. The VIP IV investor base represents a diverse group of limited partners including leading Sovereign Wealth Funds, Public and Corporate Pension Funds, Fund of Funds, Banks and Insurers, and Endowments and Foundations. The VIP IV fundraising brings Vitruvian’s assets under management to cEUR10 billion. Vitruvian is a signatory of the Principles for Responsible Investment (PRI) and an active driver of ESG principles across its portfolio companies.
VIP IV will continue Vitruvian’s proprietary thematic investment strategy of Dynamic Situations which it has pursued since founding in 2006. Vitruvian believes that the best Dynamic Situations are found in the growth buyout and growth capital phases of investment and in industry segments rich in asset- light businesses, such as technology, healthcare, financial services and business services.
Mike Risman, Managing Partner, says: We would like to express our sincere gratitude to our investors for their support, particularly in light of the unprecedented environment in which we raised VIP IV. Alongside our gratitude, we feel a weight of responsibility in being among a limited number of firms with whom our investors have entrusted their capital at this uncertain time. Our firm is conscious that many individuals and organisations have been very negatively impacted by the current situation. We hope that the companies we invest in will contribute to the recovery. We would also like to thank the outstanding entrepreneurs and management teams with whom we have partnered in our prior funds, whose vision and execution have delivered the strong returns which made this fundraising possible.
David Nahama, Senior Partner added, Vitruvian will continue to help high growth companies scale their businesses via strategic initiatives and an operational support programme designed specifically to serve entrepreneurs and high growth companies, supported by Vitruvian’s dedicated Value-Add Team. We believe that this is a unique product which drives value for both our entrepreneurial partners and our investors.
Vitruvian has invested in a number of consumer-centric technology investments including: Farfetch, Just Eat, Skyscanner, Bitdefender and Transferwise as well as enterprise-facing large companies such as Snow Software, Voxbone, CallCredit, CRF Health, CFC Insurance, Ebury, doctari, EasyPark, and WalkMe. The fundraising has been part of a very active year for Vitruvian, with several new investments including Agora, Azul, Scrive and Standish completed so far in 2020.
This article is for information purposes only.
Please remember that financial investments may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.